ConductScience.org, home

Paper339075

Mutagenicity of hydroxamic acids for Salmonella typhimurium.

Wang CY. Mutat Res, 1977. Cited by 31 papers, by iCite.

Cite this record

ConductScience Library. Mutagenicity of hydroxamic acids for Salmonella typhimurium. Papers, record 339075. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/339075

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mutagenicity of hydroxamic acids for Salmonella typhimurium.
PubMed
Journal
Mutat Res
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
31
iCite
Relative citation ratio, by iCite
1.05
iCite
Revised in PubMed
2019-07-02
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang CYC Y

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hydroxamic AcidsMajor topic
MutagensMajor topic
Genetic Techniques
Histidine
Salmonella typhimurium

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.

PMIDTitleJournalYearIn PapersSource
42614841Exploration of non-hydroxamate based quinoline analogues as HDAC8 inhibitors.RSC Adv2026https://conductscience.org/library/papers/42614841PubMed
39610753Slow-Binding and Covalent HDAC Inhibition: A New Paradigm?JACS Au2024https://conductscience.org/library/papers/39610753PubMed
38782078Replacement of the hydroxamic acid group in the selective HDAC8 inhibitor PCI-34051.Bioorg Med Chem Lett2024https://conductscience.org/library/papers/38782078PubMed
38472276Inhibition of urease-mediated ammonia production by 2-octynohydroxamic acid in hepatic encephalopathy.Nat Commun2024https://conductscience.org/library/papers/38472276PubMed
36694011Cytotoxic evaluation of YSL-109 in a triple negative breast cancer cell line and toxicological evaluations.Naunyn Schmiedebergs Arch Pharmacol2023https://conductscience.org/library/papers/36694011PubMed
34500583Non-Hydroxamate Zinc-Binding Groups as Warheads for Histone Deacetylases.Molecules2021https://conductscience.org/library/papers/34500583PubMed
31865813A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019).Expert Opin Ther Pat2020https://conductscience.org/library/papers/31865813PubMed
26603496Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors--What Some May Have Forgotten or Would Rather Forget?ChemMedChem2016https://conductscience.org/library/papers/26603496PubMed
20386668Mutagenicity of new lead compounds to treat sickle cell disease symptoms in a Salmonella/microsome assay.Int J Mol Sci2010https://conductscience.org/library/papers/20386668PubMed
3771124S.E.M. study of urease-induced crystalluria in the presence of hydroxamic derivatives.Int Urol Nephrol1986https://conductscience.org/library/papers/3771124PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/339075

GET https://conductscience.org/api/papers/v1/339075/authors